| |
 |
|
Class Information
Number: 424/85.4
Name: Drug, bio-affecting and body treating compositions > Lymphokine > Interferon
Description: Subject matter in which the lymphokine is a protein elaborated by infected host cells that protects noninfected cells from viral infection.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7597884 |
Hyperglycosylated polypeptide variants and methods of use |
Oct. 6, 2009 |
| 7588755 |
DNA sequences, recombinant DNA molecules and processes for producing human fibroblast interferon-like polypeptides |
Sep. 15, 2009 |
| RE40882 |
Antiviral nasal drops comprising recombinant interferon a biocompatible polymer and an antioxidant |
Aug. 25, 2009 |
| 7575742 |
Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist |
Aug. 18, 2009 |
| 7572437 |
Long acting human interferon analogs |
Aug. 11, 2009 |
| 7572893 |
IL-1 antagonist formulations |
Aug. 11, 2009 |
| 7547436 |
Receptor specific transepithelial transport of therapeutics |
Jun. 16, 2009 |
| 7527946 |
Interferon-beta-1a-immunoglobulin fusion proteins and uses |
May. 5, 2009 |
| 7501392 |
Method of treatment of viral hepatitis C with interferon alpha 5 |
Mar. 10, 2009 |
| 7498154 |
Nucleic acid encoding a human interferon-like protein Zcyto21 |
Mar. 3, 2009 |
| 7482014 |
Melanoma therapy |
Jan. 27, 2009 |
| 7470714 |
GM-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
Dec. 30, 2008 |
| 7449176 |
Treatment of inflammatory bowel disease with IFN-.gamma. inhibitors |
Nov. 11, 2008 |
| 7445913 |
Nucleic acid encoding a human allelic variant of interferon-like protein ZCYTO21 |
Nov. 4, 2008 |
| 7446173 |
Polymer conjugates of interferon beta-1A and uses |
Nov. 4, 2008 |
| 7435410 |
Methods of treatment with interferson and albumin fusion protein |
Oct. 14, 2008 |
| 7431921 |
Interferon beta-like molecules |
Oct. 7, 2008 |
| 7431920 |
Method of treating IL-10 deficiency |
Oct. 7, 2008 |
| 7416723 |
Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
Aug. 26, 2008 |
| 7393839 |
Polymorphic antiviral nucleoside compounds |
Jul. 1, 2008 |
| 7378387 |
Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes |
May. 27, 2008 |
| 7371372 |
Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection |
May. 13, 2008 |
| 7365165 |
IL-1 antagonist formulations |
Apr. 29, 2008 |
| 7344709 |
Treatment of hepatitis C in the Asian population with subcutaneous interferon-beta |
Mar. 18, 2008 |
| 7300656 |
Treatment of inflammatory bowel disease with IFN-gamma inhibitors |
Nov. 27, 2007 |
| 7294332 |
Combination therapy (temozolomide and .alpha.-IFN) for advanced cancer |
Nov. 13, 2007 |
| 7253261 |
Interferon-like protein Zcyto21 |
Aug. 7, 2007 |
| 7252969 |
Interferon-like protein Zcyto21 |
Aug. 7, 2007 |
| 7241870 |
Interferon-like protein Zcyto21 |
Jul. 10, 2007 |
| 7238344 |
Interferon-.beta. variants and conjugates |
Jul. 3, 2007 |
| 7235232 |
Interferon alpha hybrids |
Jun. 26, 2007 |
| 7232562 |
E38N interferon gamma polypeptide variants |
Jun. 19, 2007 |
| 7230081 |
Interferon gamma conjugates |
Jun. 12, 2007 |
| 7217413 |
Use of novel agents inducing cell death in synergy with interferons |
May. 15, 2007 |
| 7214367 |
Orally-administered interferon-tau compositions and methods |
May. 8, 2007 |
| 7208148 |
Chemically modified cytokines |
Apr. 24, 2007 |
| 7208167 |
Treatment of hepatitis C with thymosin and peptide combination therapy |
Apr. 24, 2007 |
| 7182942 |
Vaccine immunotherapy for immune suppressed patients |
Feb. 27, 2007 |
| 7160554 |
Enhanced circulation effector composition and method |
Jan. 9, 2007 |
| 7153499 |
Vaccine immunotherapy for immune suppressed patients |
Dec. 26, 2006 |
| 7150882 |
Enhanced circulation effector composition and method |
Dec. 19, 2006 |
| 7144574 |
Interferon .beta. variants and conjugates |
Dec. 5, 2006 |
| 7138546 |
Compounds and compositions for delivering active agents |
Nov. 21, 2006 |
| 7138379 |
Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons |
Nov. 21, 2006 |
| 7138376 |
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides |
Nov. 21, 2006 |
| 7118737 |
Polymer-modified synthetic proteins |
Oct. 10, 2006 |
| 7118742 |
Ligand for herpes simplex virus entry mediator and methods of use |
Oct. 10, 2006 |
| 7115263 |
Compositions and methods for treating hyperimmune response in the eye |
Oct. 3, 2006 |
| 7115578 |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
Oct. 3, 2006 |
| 7105154 |
Method of treatment using interferon-tau |
Sep. 12, 2006 |
|
|
|
